Versartis, Inc. Employee Directory
Biotechnology ResearchTexas, United States11-50 Employees
Aravive, Inc. is a late clinical-stage oncology company focused on developing targeted therapeutics to treat metastatic cancer. It is headquartered in Houston, Texas, with satellite offices in the Research Triangle Park area of North Carolina and in Bethesda, Maryland. Its technology originated in the laboratories of Dr. Amato Giaccia at Stanford University and relies on genetic screening to identify targets for cancer therapy, employing high-affinity decoy receptors to disrupt oncogenic signaling. The company's primary focus is the GAS6-AXL pathway, a signaling axis associated with cancer cell survival and metastasis. Aravive aims for its therapies to be used as monotherapy or in combination with existing cancer treatments, and it pursues development in advanced disease settings. In August 2023, the company announced that its Phase 3 trial evaluating batiraxcept in platinum-resistant ovarian cancer did not meet its primary endpoint.